logo

CAPR

Capricor·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CAPR fundamentals

Capricor (CAPR) released its earnings on Nov 10, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.54 (YoY -42.11%), met estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.54
-42.11%
Report date
Nov 10, 2025
CAPR Earnings Call Summary for Q3,2025
  • HOPE-3 Trial Milestone: Deramiocel Phase III data unblinding imminent, targeting PUL 2.0 and LVEF endpoints. FDA Type 2 submission with 6-month review period.
  • Manufacturing Readiness: Cohort B evaluates commercial-scale production; facility passed FDA pre-license inspection.
  • Financial Resilience: $98.6 million cash; R&D expenses up 66% Y/Y due to HOPE-3.
  • FDA Flexibility: Agency may consider totality of evidence if primary endpoint missed.
  • Exosome Platform: COVID-19 vaccine trial data expected Q1 2026; potential for multivalent vaccines.
  • Label Expansion: Skeletal muscle indication contingent on PDUFA outcome.
  • Regulatory Strategy: Focus on cardiomyopathy approval first; Cohort B data critical for commercial manufacturing comparability.
EPS
Revenue

Revenue & Expenses

Key Indicators

Capricor (CAPR) key financial stats and ratios, covering profitability, financial health, and leverage.
Capricor (CAPR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Capricor (CAPR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Capricor (CAPR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Capricor (CAPR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Capricor (CAPR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield